Form 8.3 - MEDICLINIC INTERNATIONAL PLC Amend
16/02/2023 18:12
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230216:nRSP2135Qa&default-theme=true
RNS Number : 2135Q Barclays PLC 16 February 2023
FORM 8.3 Amendment to Sale
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose MEDICLINIC INTERNATIONAL PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 08 February 2023
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of the offeror or
offeree
to which the disclosure relates following the dealing (if any)
Class of relevant security: 10p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 12,662,989 1.72% 4,779,315 0.65%
(2) Cash-settled derivatives:
4,689,134 0.64% 9,982,957 1.35%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 17,352,123 2.35% 14,762,272 2.00%
(b) Rights to subscribe for new securities (including directors and other
executive
options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
10p ordinary Purchase 185 4.9737 GBP
10p ordinary Purchase 336 4.9700 GBP
10p ordinary Purchase 1,206 4.9760 GBP
10p ordinary Purchase 2,936 4.9729 GBP
10p ordinary Purchase 3,334 4.9722 GBP
10p ordinary Purchase 13,488 4.9740 GBP
10p ordinary Purchase 14,379 4.9777 GBP
10p ordinary Purchase 26,928 4.9731 GBP
10p ordinary Sale 5,612 4.9714 GBP
10p ordinary Sale 13,743 4.9723 GBP
10p ordinary Sale 14,379 4.9780 GBP
10p ordinary Sale 71,479 4.9696 GBP
10p ordinary Sale 77,187 4.9735 GBP
10p ordinary Sale 210,042 4.9745 GBP
10p ordinary Sale 289,958 4.9742 GBP
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
10p ordinary SWAP Long 183 106.2399 ZAR
10p ordinary CFD Long 299 105.2470 ZAR
10p ordinary SWAP Long 343 105.7943 ZAR
10p ordinary CFD Long 345 106.2072 ZAR
10p ordinary SWAP Long 353 105.7955 ZAR
10p ordinary CFD Long 465 106.4830 ZAR
10p ordinary SWAP Long 1,350 4.9780 GBP
10p ordinary SWAP Long 1,557 105.2768 ZAR
10p ordinary SWAP Long 1,587 4.9760 GBP
10p ordinary SWAP Long 1,878 106.1600 ZAR
10p ordinary SWAP Long 4,247 4.9779 GBP
10p ordinary SWAP Long 5,612 4.9714 GBP
10p ordinary SWAP Long 10,806 4.9710 GBP
10p ordinary SWAP Long 71,479 4.9696 GBP
10p ordinary SWAP Long 72,940 4.9732 GBP
10p ordinary SWAP Long 210,042 4.9745 GBP
10p ordinary SWAP Long 289,958 4.9742 GBP
10p ordinary SWAP Short 68 4.9760 GBP
10p ordinary SWAP Short 183 106.2399 ZAR
10p ordinary SWAP Short 185 4.9737 GBP
10p ordinary SWAP Short 299 105.2786 ZAR
10p ordinary SWAP Short 343 105.7943 ZAR
10p ordinary SWAP Short 345 106.2364 ZAR
10p ordinary SWAP Short 353 105.7955 ZAR
10p ordinary SWAP Short 465 106.5123 ZAR
10p ordinary CFD Short 1,557 105.3057 ZAR
10p ordinary SWAP Short 1,878 106.1600 ZAR
10p ordinary SWAP Short 7,506 4.9722 GBP
10p ordinary SWAP Short 11,803 4.9746 GBP
10p ordinary SWAP Short 28,515 4.9731 GBP
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class Product Writing, Number Exercise Type Expiry Option
of description purchasing, of price date money
relevant selling, securities per unit paid/
security varying etc to which received
option per unit
relates
(ii) Exercising
Class of relevant Product description Exercising/ exercised against Number of Exercise price per
security securities unit
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of Dealings Details Price per unit (if
security applicable)
4. OTHER INFORMATION
(a) Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding,
formal or informal, relating to relevant securities which may be an inducement
to deal
or refrain from dealing entered into by the person making the disclosure and
any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant
securities to which
any derivative is referenced:
NONE
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 16 Feb 2023
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RETGZGMZRVLGFZM